Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[BCG vaccination]

F Natali1, P Ramon

  • 1Service de Pneumologie, Hôpital d'Instruction des Armées D. Larrey, Versailles.

Revue De Pneumologie Clinique
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

The BCG vaccine protects 70-80% of children against severe tuberculosis. Research is ongoing to better understand its mechanisms and duration of protection, with minimal complications observed in HIV-positive individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A 60-Year-Old Man With a Migratory Lobar Consolidation After Invasive Ventilation.

Chest·2023
Same author

Diagnostic role of internal mammary lymph node involvement in tuberculous pleurisy: a multicenter study.

Pulmonology·2022
Same author

Atomic scale investigation of the volume phase transition in concentrated PNIPAM microgels.

The Journal of chemical physics·2020
Same author

Removable capping layer for air-sensitive GdN.

Nanotechnology·2020
Same author

Surviving salt fluctuations: stress and recovery in Halobacterium salinarum, an extreme halophilic Archaeon.

Scientific reports·2020
Same author

Brain lateralization probed by water diffusion at the atomic to micrometric scale.

Scientific reports·2019
Same journal

[Respiratory Medicine and Research: The new SPLF's anglophone journal].

Revue de pneumologie clinique·2018
Same journal

[Medical journals publication: Let's change].

Revue de pneumologie clinique·2018
Same journal

[Multiple ulcerated tracheobronchial mucosal lesions in the eosinophilic granulomatosis with polyangiitis].

Revue de pneumologie clinique·2018
Same journal

[Medium and long-term respiratory outcome in patients operated from congenital diaphragmatic hernia: From a series of 56 patients].

Revue de pneumologie clinique·2018
Same journal

[Sporadic lymphangioleiomyomatosis: A rare cause of bilateral spontaneous pneumothorax in young woman].

Revue de pneumologie clinique·2018
Same journal

[COPD and smoking cessation: Patients' expectations and responses of health professionals].

Revue de pneumologie clinique·2018
See all related articles

Area of Science:

  • Immunology
  • Infectious Diseases
  • Public Health

Context:

  • Tuberculosis (TB) remains a significant global health challenge.
  • The Bacillus Calmette-Guérin (BCG) vaccine is the primary vaccine used against TB.
  • Socioeconomic, sanitary conditions, and HIV infection impact TB spread.

Purpose:

  • To review the protective effects and limitations of the BCG vaccine.
  • To explore the mechanisms and duration of BCG-induced protection.
  • To assess BCG vaccine complications in HIV-positive subjects.

Summary:

  • BCG vaccine offers 70-80% protection against severe tuberculosis, particularly in children.
  • Its epidemiological impact is moderate due to various influencing factors.
  • Complications in HIV-positive individuals are minimal, contrary to expectations.

Related Experiment Videos

  • Tuberculosis eradication policies vary globally based on infection risk.
  • There is a resurgence of research interest in BCG vaccination.

    • Impact:

    • Highlights the established efficacy of BCG against severe TB forms.
    • Identifies knowledge gaps regarding BCG's precise mechanisms and protection duration.
    • Provides insights into BCG safety in immunocompromised populations.
    • Informs public health strategies for TB control and vaccination policies.